院前超声在未分化呼吸困难中的应用(PreLUDE):一项前瞻性临床观察研究
本研究为前瞻性观察研究,纳入214例成人呼吸困难患者,由院前重症医师先基于临床检查登记疑似诊断,再行心脏和肺部POCUS后再次登记诊断,与终点委员会裁定诊断比较。主要结局为急性心衰诊断敏感性,POCUS前58%(95%CI 46%-69%) vs POCUS后65%(95%CI 53%-75%)(p=0.12)。急性心衰诊断ROC AUC由0.72(95%CI 0.66-0.78)升至0.79(95%CI 0.73-0.84)(p<0.001),AE-COPD/哮喘诊断ROC AUC由0.87(95%CI 0.82-0.91)升至0.93(95%CI 0.88-0.97)(p<0.001)。作者认为,针对性使用POCUS发现可优化急性心衰的排除和确认诊断准确性。
要点
- 院前POCUS使急性心衰诊断ROC AUC从0.72(95%CI 0.66-0.78)升至0.79(95%CI 0.73-0.84)(p<0.001),但敏感性从58%(95%CI 46%-69%)升至65%(95%CI 53%-75%)未达统计学显著(p=0.12)。
- 严重左室功能减低、双侧B线或双侧胸腔积液中任一发现对急性心衰敏感性最高,为88%(95%CI 79%-94%)。
- 上述三项发现同时存在时特异性最高,达99%(95%CI 95%-100%)。
- AE-COPD/哮喘诊断ROC AUC由POCUS前0.87(95%CI 0.82-0.91)升至POCUS后0.93(95%CI 0.88-0.97)(p<0.001)。
- POCUS导致53/214(25%)患者诊断重新分类;POCUS前后疑似急性心衰均为64/214(30%),终点委员会裁定急性心衰87/214(41%)。
适用人群与场景
- 成人呼吸困难患者,院前场景,由院前重症医师评估。
处置流程与药物剂量
- 院前重症医师先基于临床检查登记疑似诊断,再行心脏和肺部POCUS,最后基于临床检查补充POCUS登记疑似诊断。
研究设计与关键结果
- 研究类型:前瞻性观察研究;样本量214例;人群:成人呼吸困难患者;干预:院前POCUS(心脏和肺部);对照:临床检查 alone;主要终点:急性心衰诊断敏感性POCUS前58%(95%CI 46%-69%) vs POCUS后65%(95%CI 53%-75%)(p=0.12)。
- 关键次要终点:急性心衰诊断ROC AUC POCUS前0.72(95%CI 0.66-0.78) vs POCUS后0.79(95%CI 0.73-0.84)(p<0.001);AE-COPD/哮喘诊断ROC AUC POCUS前0.87(95%CI 0.82-0.91) vs POCUS后0.93(95%CI 0.88-0.97)(p<0.001)。
- POCUS导致53/214(25%)患者诊断重新分类;POCUS前后疑似急性心衰均为64/214(30%);终点委员会裁定急性心衰87/214(41%)。
- 严重左室功能减低、双侧B线或双侧胸腔积液中任一发现对急性心衰敏感性88%(95%CI 79%-94%);三项同时存在时特异性99%(95%CI 95%-100%)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,补充院前POCUS可提高急性心衰和AE-COPD/哮喘的整体诊断准确性(以ROC AUC描述),但急性心衰诊断敏感性的提高未达统计学显著。
- 作者认为,针对性使用POCUS发现可优化急性心衰的排除和确认诊断准确性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Diagnostic uncertainty in patients with dyspnea is associated with worse outcomes. We hypothesized that prehospital point-of-care ultrasound (POCUS) can improve diagnostic accuracy.
METHODS: Prospective observational study of adult patients suffering dyspnea. Prehospital critical care physicians registered a suspected diagnosis based on clinical examination alone, performed POCUS of the heart and lungs, and finally registered suspected diagnoses based on their clinical examination supplemented with POCUS. Pre- and post-POCUS diagnoses were compared to endpoint committee adjudicated diagnoses. The primary outcome was improved sensitivity for diagnosing acute heart failure. Secondary outcomes included other diagnostic accuracy measures in relation to acute heart failure and other causes of dyspnea.
RESULTS: In total, 214 patients were included. The diagnosis of acute heart failure was suspected in 64/214 (30%) of patients before POCUS and 64/214 (30%) patients after POCUS, but POCUS led to reclassification in 53/214 (25%) patients. The endpoint committee adjudicated the diagnosis of acute heart failure in 87/214 (41%) patients. The sensitivity for the diagnosis of acute heart failure was 58% (95% CI 46%-69%) before POCUS compared to 65% (95% CI 53%-75%) after POCUS (p = 0.12). ROC AUC for the diagnosis acute heart failure was 0.72 (95% CI 0.66-0.78) before POCUS compared to 0.79 (0.73-0.84) after POCUS (p < 0.001). ROC AUC for the diagnosis acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD) or asthma was 0.87 (0.82-0.91) before POCUS and 0.93 (0.88-0.97) after POCUS (p < 0.001). A POCUS finding of any of severely reduced left ventricular function, bilateral B-lines or bilateral pleural effusion demonstrated the highest sensitivity for acute heart failure at 88% (95% CI 79%-94%), whereas the combination of all of these three findings yielded the highest specificity at 99% (95% CI 95%-100%).
CONCLUSION: Supplementary prehospital POCUS leads to an improvement of diagnostic accuracy of both heart failure and AE-COPD/-asthma overall described by ROC AUC, but the increase in sensitivity for the diagnoses of acute heart failure did not reach statistical significance. Tailored use of POCUS findings optimizes diagnostic accuracy for rule-out and rule-in of acute heart failure.
TRIAL REGISTRATION: Registered in Clinical Trials, 05.04.2019 (identifier: NCT03905460) https://clinicaltrials.gov/ct2/show/study/NCT03905460?term=NCT03905460&cond=Dyspnea&cntry=DK&draw=2&rank=1 .
参考来源
- Gundersen EA, Juhl-Olsen P, Bach A, et al. PrehospitaL Ultrasound in Undifferentiated DyspnEa (PreLUDE): a prospective, clinical, observational study. Scand J Trauma Resusc Emerg Med. 2023. PMID: 36740691. doi:10.1186/s13049-023-01070-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。